Welcome to Broadline Capital
Founded in 2005, Broadline Capital is a global alternative investment firm focused primarily on growth capital and impact investments in North America and Asia. At Broadline, we're inspired by champions — people of vision and courage — whose ideas can positively change the world, and who are ready to transform their ideas into the next big, industry-changing company.
When evaluating opportunities, we seek category leaders and category creators that are reshaping their industry. We prefer highly-charged sectors where innovation, growth, strong margins, and market consolidation are yielding abundant opportunities. Ultimately, we seek companies that are well-positioned to thrive as the world continues to transition toward an economy increasingly driven by healthy living and the pursuit of a more efficient and sustainable way of life.
Broadline places special emphasis on collaborating with management teams who can demonstrate the credibility and capability to benefit from Broadline's established platform, access to industry expertise, and vast network of relationships built over many years. Our transaction leaders have spent their entire careers building trust-based relationships globally. They have led some of the most creative deals in the history of their market categories. Their collective experience and relationships help assure that Broadline-sponsored companies have high potential to develop to the next level. We believe Broadline’s current investing opportunities are among the most exciting on the planet.
New York | Miami | Columbus | Seoul | Shanghai
Broadline's proprietary investment process is designed to stretch alpha at every link of the investment value chain, from deal origination, evaluation, structuring and execution — to governance oversight and exit cultivation. Broadline's past success stems from its multi-channel sourcing, disciplined investment selection, and creative mitigation structuring:
First, Broadline starts with a "Top-Down" approach to identify targeted categories that are positioned to create broad impact as the world continues to transition toward an economy increasingly driven by healthy living and the pursuit of a more efficient and sustainable way of life, and where a combination of factors are generating an abundance of opportunities.
Next, Broadline takes a "Bottom-Up" approach to identify rising category leaders and category creators who are helping to reshape their industry, and whose management teams display the credibility and readiness to develop their business to the next level.
Broadline seeks less correlated investment risk by pursuing diversification across industries, geographies, transaction sizes, deal structures, development stages, and market capitalizations.
We invite you to scroll through case examples of portfolio companies below. If you are a current Broadline registered investor, please click on the "Investor Login" button at the top of the website for management updates and reports from companies in your investment portfolio and to review examples from our current pipeline of prospective opportunities.
Category: Healthcare & Life Sciences
Industry: Healthcare & Life Sciences
Sub-category: Non-Invasive Medical Devices
Founded in 2006, EndoSphere is a medical technology company that has developed a first-in-class, non-invasive medical device that endoscopically treats one of the world's largest healthcare issues: Metabolic Diseases including Obesity, Type 2 Diabetes, and Fatty Liver Disease. Endosphere's flagship device, the SatiSphere™ system, is incisionless, reversible and repeatable. In clinical studies, the SatiSphere™ device has enabled Obese patients to achieve significant Excess Weight Loss (EWL) without the need for surgery or medication, providing an alternative to traditional restrictive devices and surgeries.
New Device Category: EndoSphere has developed a completely new category of "Endo-Metabolic" devices. Unlike traditional "restrictive" devices which work against nature, EndoSphere's devices use the body's natural physiological responses to food intake to accelerate satiety and recalibrate brain-gut metabolic feedback loops. They are highly differentiated as Physiologic-amplifying, Hormonal-regulating, Satiety-managing, and Insulin-balancing devices.
Unique Focus on the Duodenum: Unlike other weight-loss treatments which focus on restricting available capacity of the Stomach, EndoSphere focuses on the Duodenum, which is widely recognized as the body's Metabolic Control Center. The Duodenum plays important roles in multiple functions, including: Digestion, Appetite/Satiety regulation, Insulin management, and Drug Delivery.
EndoSphere's original version of its SatiSphere anti-obesity device received CE Mark regulatory approval in 31 countries, and an improved version of the product has already entered the clinical stage of development. EndoSphere's portfolio of patent assets is 100% company-owned, free from any third-party licensing or royalty obligations. EndoSphere received the industry's "Fierce15" award, an annual recognition of the world's top 15 most promising privately-held medical innovations. For more information, please visit https://www.EndoSphereInc.com.
Category: Sustainability & Environment
Industry: Environment & Sustainability
Sub-Category: carbon-free Energy Storage
Founded in 2010, Powermers has developed patented advanced materials that enable the world's first Carbon-Free Lithium-ion Battery Cathodes that demonstrate superior Safety and Performance over batteries using conventional materials.
Superior Safety: By replacing conventional Carbon and Binders (the non-conductive "deadweight" components of a traditional cathode) with Powermers' patented conductive polymers, Powermers' technology reduces the Thermal Runaway Risks -- dramatically increasing the Safety of high-voltage lithium-ion batteries. In the past, thermal Runaway Risk has caused billions of losses in value for companies whose products rely on high-voltage lithium-ion batteries. Safety is well recognized as the top risk factor facing businesses whose products rely on high-voltage lithium-ion batteries because of the inherent risk that thermal runaway can create for over-heating, combustibility, and even explosions.
Superior Performance: In addition to dramatically increasing battery Safety, replacing the conventional Cathode's "deadweight" components with Powermers' conductive polymers also expands the resulting battery's Active Material Limit, resulting in Increased Specific Energy. Importantly, unlike most other battery innovations, Powermers' technology enables these Safety and Specific Energy performance improvements without sacrificing other Key Performance Measurements including: Power, Cycle Life, Weight, and Cost per KWH.
Easily Incorporated into Manufacturers' Existing Production Processes: Powermers' patented transition metal-based polymers are easily integrated into battery manufacturers' existing facilities, as they do not require any significant change to established manufacturing processes. We believe enabling rapid adoption by the industry will be a critical success factor for Powermers' battery innovations. Its patented polymers are also affordable, as they contain no precious metals, and yet they serve as highly-efficient catalysts. In fact, they demonstrate higher catalytic functionality than the pure noble-metal catalysts including gold, platinum, and palladium. For these reasons, we believe companies like Samsung in the consumer electronics industry and Tesla in the electric vehicle industry will greatly benefit from incorporating Powermers' technology into their future products' batteries -- providing a new level of consumer confidence in the Safety and Performance of their products for future generations.
Powermers' performance and safety results have been repeatedly validated by two of the industry's recognized independent third-party battery testing labs including the US Army Corps of Engineers' CERL Battery Innovation Labs in Champaign, Illinois, as well as The Ohio State University's Center for Automotive Research Labs in Columbus, Ohio. Powermers owns 100% of its IP asset portfolio, free from any third-party licensing or royalty obligations. For more information, please visit https://www.Powermers.com.
Broadline's principals are past entrepreneurs and CEOs of successful companies where they created significant value and negotiated quality exits for themselves and their investors. They have spent their entire careers building trust-based relationships globally, and have led some of the most creative deals in the history of their categories. They understand what it takes to build a business from the ground up, because they've been there. Staying close to their roots as former company operators, they love collaborating with inspired and talented management teams to build something truly special.
At Broadline Capital, we are inspired by champions – people of vision and courage – whose ideas can positively change the world, and who are ready to transform their ideas into the next big, industry-changing companies. If you share our perspective, we invite you to join us. We look forward to hearing from you. Inquiries from Qualified and Accredited Investors are directed to contact us at: Info@BroadlineCapital.com.
MANHATTAN: 1 Rockefeller Plaza, 11th Floor, New York, NY 10020
MIAMI: 801 Brickell Avenue, 9th Floor, Miami, FL 33131
Broadline ® is a Registered Trademark.
Copyright © Broadline Capital 2005-2020
All Rights Reserved.